Diabetes drug metformin partly works by altering gut bacteria

One more study has shown that metformin that is commonly prescribed to people with Type-2 diabetes alters the gut bacteria. While earlier studies have shown a difference in the gut bacteria population with metformin intake, the latest study published in Nature Medicine finds the altered gut bacteria mediates some of therapeutic benefits of the drug. … Continue reading Diabetes drug metformin partly works by altering gut bacteria

Using a diabetes drug to treat TB shows promise

Thanks to metformin, a drug that is commonly prescribed for type 2 diabetes patients, treating TB — both the drug-sensitive and drug-resistant types — may become far more effective if clinical trials in humans produce the same results as laboratory and animal studies. According to a study published today (November 20) in the journal Science … Continue reading Using a diabetes drug to treat TB shows promise

Metformin: no cardiovascular benefit for non-diabetics

Contrary to high expectations, an 18-month trial involving 173 subjects without diabetes has shown that metformin treatment did not reduce the risk factors for cardiovascular disease. This is the first ever large trial undertaken to study the effect of the drug in reducing the cardiovascular risk factors in people without diabetes. The study has been … Continue reading Metformin: no cardiovascular benefit for non-diabetics